peptoid-peptide analogs of MTI-101 (Modulation Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namepeptoid-peptide analogs of MTI-101 (Modulation Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionCD44 antigen inhibitors
TargetsCD44 antigen
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesModulation Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesModulation Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A